KSM-66 Ashwagandha: The Adaptogen the Research Actually Supports for Perimenopause

There is a reason ashwagandha has survived 3,000 years of Ayurvedic practice. Most ancient botanical traditions contain some wisdom worth unpacking — but few have held up as consistently under modern scientific scrutiny as Withania somnifera, the plant known in Sanskrit as ashwagandha: “smell of horse,” so named for both the earthy scent of its root and the vitality it was believed to confer.

For women in perimenopause navigating elevated cortisol, disrupted sleep, anxious thinking, and the general sense that their body’s stress thermostat has been turned up, the evidence for this adaptogen is genuinely compelling. Not because it is a panacea — it is not — but because the mechanism is real, the clinical data is reproducible, and the effects on some of the most stubborn symptoms of hormonal transition are meaningful.

Here is what the science actually shows.

What is ashwagandha and why does the extract form matter?

Withania somnifera is a small evergreen shrub native to India, North Africa, and the Mediterranean. It belongs to the same family as the tomato. The medicinal value lies in the root — and specifically in a class of compounds called withanolides, steroidal lactones that are responsible for most of ashwagandha’s measurable physiological effects.

Not all ashwagandha supplements are equivalent. The majority of the clinical trials that produced meaningful results used standardised, full-spectrum root extracts — and the most studied of these is KSM-66, a patented extract developed by Ixoreal Biomed that is standardised to a minimum of 5% withanolides by HPLC. It is produced without alcohol or synthetic solvents, drawn exclusively from the root (not leaves, which have a different and less well-studied withanolide profile), and has more published clinical trials behind it than any other ashwagandha extract on the market.

This matters practically: when you see a supplement containing “ashwagandha root powder” at a low price point, you are likely getting an unstandardised product with highly variable withanolide content. The dose you are taking is, in effect, unknown.

The mechanism: what ashwagandha actually does to your stress response

To understand why ashwagandha is relevant to perimenopause, you first need to understand the HPA axis — the hypothalamic-pituitary-adrenal axis — which is the central command system governing your body’s stress response.

When you perceive a stressor — physical, psychological, or hormonal — the hypothalamus releases corticotropin-releasing hormone (CRH), which signals the pituitary to release ACTH, which in turn signals the adrenal glands to produce cortisol. This is an elegant, ancient survival system. The problem, in midlife, is that it becomes chronically dysregulated.

Perimenopause itself is a neuroendocrine event. The fluctuating and declining oestrogen levels of the perimenopausal transition directly affect glucocorticoid receptor sensitivity in the brain — making the HPA axis more reactive, not less. This is why so many women describe a feeling of wired-but-tired in perimenopause: the stress response threshold has lowered, cortisol is being produced in response to stimuli that previously wouldn’t have triggered it, and the feedback loop that should turn cortisol off is less efficient.

Withanolides — the active compounds in KSM-66 — work through multiple converging pathways to moderate this response. They appear to restore glucocorticoid receptor sensitivity on the hypothalamus and pituitary (the feedback mechanism that says “enough cortisol, stand down”), reduce the activity of enzymes involved in cortisol synthesis in the adrenals, and modulate GABAergic signalling in ways that produce a calming effect without sedation. This is the definition of an adaptogen: it does not blunt the stress response entirely — it recalibrates it towards homeostasis.

The clinical evidence: what the trials actually show

The most-cited trial is the Chandrasekhar et al. (2012) double-blind, randomised, placebo-controlled study published in the Indian Journal of Psychological Medicine. Sixty-four adults with a history of chronic stress took either 300mg of KSM-66 twice daily or placebo for 60 days. The results were significant across every measure:

• Perceived Stress Scale scores reduced significantly (p<0.0001) in the ashwagandha group
• Serum cortisol levels fell by 27.9% (p=0.0006)
• All five stress-assessment instruments showed significant improvement over placebo
• No serious adverse events were recorded

These are not modest effects. A nearly 28% reduction in serum cortisol is clinically meaningful — comparable to some pharmaceutical interventions, achieved with a botanical extract that has been safely used for millennia.

A subsequent 8-week randomised controlled trial using 600mg/day of KSM-66 found that participants reported a 44% reduction in stress scores and a 32% reduction on the Perceived Stress Scale, alongside improvements in sleep quality, energy levels, and general wellbeing.

For women specifically, a randomised controlled trial in perimenopausal women (300mg twice daily for 8 weeks) found significant reductions in hot flushes, night sweats, and anxiety scores compared to placebo — with improvements also noted in sleep onset and quality. This is the trial most directly relevant: real data, in perimenopausal women, showing measurable symptom improvement.

Ashwagandha and sleep: the evidence is particularly strong here

Sleep disruption is one of the most common and most distressing symptoms of perimenopause — and one of the most biologically damaging. Poor sleep directly accelerates biological ageing: it impairs DNA repair mechanisms, disrupts growth hormone secretion, elevates night-time cortisol, and compromises the glymphatic clearance of metabolic waste from the brain that only happens during deep sleep.

A double-blind randomised controlled trial published in PLOS ONE (Langade et al., 2019) enrolled 60 adults with insomnia and gave them either 300mg of ashwagandha root extract twice daily or placebo for 10 weeks. The KSM-66 group showed significant improvements in:

• Sleep onset latency — time taken to fall asleep reduced
• Total sleep time — meaningful increase in actual sleep duration
• Sleep efficiency — proportion of time in bed actually spent sleeping
• Wake after sleep onset — fewer awakenings through the night
• Mental alertness on rising — subjective morning readiness improved

This matters for a specific biological reason. The active withanolide most implicated in ashwagandha’s sleep effects is triethylene glycol, which appears to promote non-rapid eye movement (NREM) sleep — the slow-wave, restorative deep sleep phase that is most disrupted in perimenopause and most associated with cellular repair. This is not simply a sedative effect. The mechanism is different from antihistamines or benzodiazepines — it is working with the body’s natural sleep architecture, not overriding it.

If you wake between 2am and 4am — a pattern common in perimenopause and often attributed to cortisol surges and blood sugar fluctuations — ashwagandha addresses the upstream driver rather than simply masking the symptom. We explored the full 3am wake-up mechanism in this post — ashwagandha works best as part of a broader approach to evening cortisol regulation.

The thyroid connection: what to know

One area that deserves careful mention is ashwagandha’s effect on thyroid function. Several studies have found that ashwagandha supplementation is associated with increases in T3 (triiodothyronine) and T4 (thyroxine) and reductions in TSH (thyroid-stimulating hormone) — effects consistent with supporting thyroid hormone production in subclinically hypothyroid individuals.

For women in perimenopause with subclinical hypothyroidism (a not uncommon finding in this demographic, and frequently underdiagnosed), this could be a meaningful secondary benefit. However, if you are already taking thyroid medication — levothyroxine or similar — this is something to discuss with your GP before adding ashwagandha, as it could influence your required dose. This is not a contraindication, but it is a conversation worth having.

Ashwagandha and biological age: the emerging picture

The connection between ashwagandha and biological ageing is still emerging — but it is mechanistically coherent with what we know from the Fitzgerald epigenetic research.

Chronic cortisol elevation is one of the most well-established accelerators of epigenetic ageing. Cortisol influences DNA methylation patterns at specific CpG sites — particularly those associated with inflammatory gene expression, immune regulation, and cellular senescence. Studies using Horvath DNAmAge clock analyses have found that high perceived stress and elevated cortisol correlate with measurably older epigenetic age, independent of other lifestyle factors.

Ashwagandha’s ability to reduce serum cortisol by approximately 28% is not just a symptomatic win — it is, at the cellular level, removing one of the key drivers of accelerated epigenetic ageing. This is the mechanism connecting stress management to The Cellular Reset programme: cortisol regulation is not a soft, wellness-adjacent addition to the protocol. It is one of the seven core habits, included precisely because the biological evidence shows it has measurable downstream effects on how quickly or slowly your cells age.

Additionally, ashwagandha has been shown to reduce markers of oxidative stress — including malondialdehyde (MDA) and reactive oxygen species — both of which are direct contributors to cellular damage and accelerated ageing at the mitochondrial level.

Dosing, timing, and what to look for

The clinical trial evidence clusters around two effective doses:

• 300mg twice daily — the dose used in the Chandrasekhar cortisol trial and the perimenopausal women’s RCT
• 600mg once daily — used in several sleep and stress trials with equivalent outcomes

Results in the clinical trials became measurable at 4–8 weeks, with the most significant changes at 8–12 weeks. This is consistent with the way adaptogens work: they are not acute interventions but cumulative modulators. Expect a few weeks before noticing a shift.

Timing: Most people find ashwagandha well tolerated at any time of day. For sleep benefits specifically, taking it in the evening (with dinner or shortly before bed) is supported by some evidence. If you are sensitive to any adaptogen affecting energy, start with an evening dose and adjust from there.

What to look for on the label: KSM-66 certification, standardised to minimum 5% withanolides, root-only extract (not leaf), no synthetic fillers or anti-caking agents. The Time Health formulation meets all of these criteria — 600mg KSM-66 per serving (6,000mg wholefood equivalent), vegan capsules, made in the UK under GMP-certified manufacturing standards.

If you are considering adding a high-quality KSM-66 supplement to your routine, Time Health’s Organic KSM-66 Ashwagandha is the product I use and recommend. It is the same extract used in the clinical trials, at the clinically studied dose, without synthetic bulking or anti-caking agents. You can use the link above to purchase directly — as a Time Health affiliate, I receive a small commission at no extra cost to you.

Who should use ashwagandha — and who should be cautious

Well suited to: Women in perimenopause experiencing elevated stress, anxiety, sleep disruption, the wired-but-tired pattern, morning cortisol spikes, or difficulty winding down. Also appropriate for anyone whose stress levels are undermining the other health habits they are trying to build — since cortisol dysregulation impairs sleep quality, gut function, blood sugar regulation, and nutrient absorption simultaneously.

Use with caution or discuss with your GP if: You are pregnant or breastfeeding (some traditional texts contraindicate it; clinical data is insufficient). You have an autoimmune condition (ashwagandha is immunomodulatory). You take thyroid medication. You have a nightshade sensitivity — Withania somnifera is a member of the Solanaceae family. You have a history of hormone-sensitive conditions — discuss with your healthcare provider, as the evidence on oestrogen-like effects is mixed and context-dependent.

A 2024 case report in the literature did describe HPA axis suppression in a postmenopausal woman using ashwagandha at high doses over a prolonged period — a reminder that even botanical adaptogens used chronically and in high doses warrant monitoring. Standard supplementation at studied doses appears safe for 12-month durations based on current clinical data.

Where ashwagandha fits in the bigger picture

Ashwagandha is not a shortcut. It will not replace sleep, it will not compensate for a diet that chronically spikes cortisol, and it will not override the structural stressors that are driving your nervous system into overdrive. What it does — and does well, in the evidence — is lower the baseline. It recalibrates the HPA axis towards a more measured response. It removes some of the physiological noise that makes it harder to sleep, harder to think clearly, and harder to hold the habits that genuinely reverse biological ageing over time.

In The Cellular Reset, stress management is one of the seven habits tracked daily through the companion app. The protocol is not prescriptive about supplements — but for women whose cortisol patterns are actively undermining their progress, KSM-66 ashwagandha is one of the most evidence-based additions available.

Further reading

• The 3am Wake-Up: Cortisol, Blood Sugar, or Both?
• The Methylation Diet: What to Eat to Reverse Your Biological Age
• How Polyphenols Talk to Your DNA

Scientific references

• Chandrasekhar, K., Kapoor, J. & Anishetty, S. (2012). A prospective, randomised double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262.
• Langade, D. et al. (2019). Efficacy and safety of ashwagandha root extract in insomnia and anxiety. PLOS ONE. Double-blind RCT, 60 subjects, 10 weeks.
• Agarwal, R. et al. (2023). Efficacy and safety of ashwagandha root extract on reproductive system in perimenopausal women. Randomised controlled trial.
• Lopresti, A.L. et al. (2022). An investigation into the stress-relieving and pharmacological actions of ashwagandha root extract. Medicine.
• Wankhede, S. et al. (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery. Journal of the International Society of Sports Nutrition.

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. This post contains affiliate links — I receive a small commission on purchases made through them, at no extra cost to you. I only recommend products I use and trust. Always consult a qualified healthcare professional before adding new supplements to your routine, particularly if you have an existing health condition, take prescription medication, or are pregnant or breastfeeding.